SNC
BSX icon

Stifel Nicolaus & Co’s Boston Scientific BSX Stock Holding History

Stifel Nicolaus & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3.75M Sell
319,807
-106
-0% -$1.15K 0.06% 300
2013
Q2 		$2.97M Buy
+319,913
New +$2.71M 0.05% 324

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Stifel Nicolaus & Co's BSX Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its Boston Scientific (BSX) stake by 0.03% in Q3 2013, selling an estimated $1.15K and leaving 319,807 shares worth $3.75M. The position accounts for 0.06% of the portfolio, ranked #300.

Stifel Nicolaus & Co first reported a position in BSX in Q2 2013 and has held it in 2 quarters since. 419 funds tracked by Wall St. Rank hold BSX as of Q3 2013.

  • Stifel Nicolaus & Co held 319,807 shares of Boston Scientific worth $3.75M as of Q3 2013.
  • Stifel Nicolaus & Co sold 106 Boston Scientific shares in Q3 2013, an estimated $1.15K.
  • Boston Scientific made up 0.06% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #300 holding.
  • Stifel Nicolaus & Co first reported a position in Boston Scientific in Q2 2013 and has held it in 2 quarters since.
  • 419 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.